Home/Filings/4/0001193125-25-325383
4//SEC Filing

Estepan Ian Michael 4

Accession 0001193125-25-325383

CIK 0000873303other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 8:05 PM ET

Size

5.5 KB

Accession

0001193125-25-325383

Insider Transaction Report

Form 4
Period: 2025-12-16
Estepan Ian Michael
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-12-16$22.31/sh13,187$294,202193,300 total
Footnotes (2)
  • [F1]Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.35 to 22.29, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0001836254

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 8:05 PM ET
Size
5.5 KB